Results 301 to 310 of about 297,887 (387)

Effects of metformin on transcriptomic and metabolomic profiles in breast cancer survivors enrolled in the randomized placebo-controlled MetBreCS trial. [PDF]

open access: yesSci Rep
Strømland PP   +14 more
europepmc   +1 more source

Identification of Senomorphic miRNAs in Embryonic Progenitor and Adult Stem Cell‐Derived Extracellular Vesicles

open access: yesAging Cell, EarlyView.
A senomorphic miRNA cocktail (E5), consisting of miR‐181a‐5p, miR‐92a‐3p, miR‐21‐5p, and miR‐186‐5p, was identified from a pool of miRNAs enriched in extracellular vesicles (EVs) derived from multiple functional human stem cell types. E5 reduces senescence and SASP markers both in cell culture and in aged mice.
Tianpeng Zhang   +11 more
wiley   +1 more source

Modulation of the Antitumor Response to Metformin, Caffeine, and Sodium Dichloroacetate by the Hypoxic Microenvironment in Lung Cancer Cells. [PDF]

open access: yesInt J Mol Sci
Garcia-Martin MO   +18 more
europepmc   +1 more source

Metformin as a Tool to Target Aging.

open access: yesCell Metabolism, 2016
N. Barzilai   +3 more
semanticscholar   +1 more source

Identifying Age‐Modulating Compounds Using a Novel Computational Framework for Evaluating Transcriptional Age

open access: yesAging Cell, EarlyView.
RNAge is a transcriptional based computational approach to measure changes in cellular age upon experimental manipulation. In silico screening of a database of transcriptional changes from drug perturbations identified a novel aging agent that was applied to an hPSC model of neurodegenerative disease to trigger a late‐onset phenotype.
Chao Zhang   +8 more
wiley   +1 more source

Long-term effects of metformin on offspring health: A review of current evidence and future directions. [PDF]

open access: yesDiabetes Obes Metab
Mayadunne T   +6 more
europepmc   +1 more source

SGLT2 Inhibition by Enavogliflozin Significantly Reduces Aβ Pathology and Restores Cognitive Function via Upregulation of Microglial AMPK Signaling in 5XFAD Mouse Model of Alzheimer's Disease

open access: yesAging Cell, EarlyView.
SGLT2 inhibition with Enavogliflozin significantly improves cognitive function and reduces Aβ pathology in the 5XFAD mouse model of Alzheimer's disease. Through AMPK activation, Enavogliflozin enhances microglial mitochondrial function and Aβ phagocytosis while reducing neuroinflammation.
Jihui Han   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy